Heart Failure is a disease of ageing and is rising in prevalence throughout the developed world. It is the single most common unplanned admission diagnosis in most of the developed world. In the last 8 years there’s been a massive influx of new therapies for the management of heart failure. What are they? When and where do they fit in? Is quality of life being sacrificed in the pursuit of quantity of life?